Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer
NCT04489745 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2020-07-28
Summary
This is a trial of 5 fraction SBRT combined with androgen deprivation therapy for patients with localized high-risk or unfavorable intermediate risk prostate cancer
Conditions
Interventions
- RADIATION
-
SBRT
- DRUG
-
Androgen deprivation therapy (ADT)
Sponsors & Collaborators
-
VA Greater Los Angeles Healthcare System
lead FED
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2022-01-31
- Completion
- 2025-01-31
More Related Trials
-
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
NCT06235697 ·Status: RECRUITING ·Phase: PHASE3
-
Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate
NCT02064036 ·Status: COMPLETED ·Phase: PHASE1
-
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
NCT03298087 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Castration-Resistant Prostate Cancer with Oligometastases
NCT02685397 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
NCT03056638 ·Status: TERMINATED ·Phase: PHASE3
-
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
NCT00528866 ·Status: COMPLETED ·Phase: PHASE2
-
Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
NCT03644303 ·Status: COMPLETED ·Phase: NA
-
Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer
NCT05628363 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer
NCT00388804 ·Status: TERMINATED ·Phase: PHASE3
-
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00006359 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)
NCT01856855 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma Prostate
NCT01255891 ·Status: COMPLETED ·Phase: PHASE2
-
Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer
NCT04983095 ·Status: RECRUITING ·Phase: NA
-
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003124 ·Status: COMPLETED ·Phase: PHASE2
-
NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma
NCT02805894 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
NCT00567580 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
NCT04262154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
NCT00175396 ·Status: UNKNOWN ·Phase: PHASE3
-
Checkpoint Inhibitors and SBRT for MCRPC
NCT05655715 ·Status: COMPLETED ·Phase: PHASE2
-
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
NCT01985828 ·Status: COMPLETED ·Phase: NA
-
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00936390 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone
NCT00223145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation for Prostate Oligometastases
NCT02680587 ·Status: COMPLETED ·Phase: PHASE2
-
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
NCT07219303 ·Status: RECRUITING ·Phase: NA